Pfizer Stock News

A new age-appropriate formulation of the Pfizer BioNTech COVID-19 vaccine (Comirnaty) for use in children aged 5 to 11 years old has been approved today by the Medicines and Healthcare…

Pfizer Inc. (NYSE: PFE) has released additional data from the clinical trial of its oral COVID-19 drug. The company found that Paxlovid, the antiviral, was 89% efficient in protecting high-risk populations from dying or hospitalization due to COVID-19. The total dose consists of three pills taken two times a day for five days. It prevents […] The post Pfizer Inc. (NYSE: PFE) Releases More Data on Its Oral Drug for COVID-19 appeared first on Wall Street PR .

The move follows the approval of a similar dose of the Pfizer vaccine earlier this month

New Delhi: In the last 24 hours, India has reported 7,495 new cases of the novel coronavirus, as well as 434 deaths from the infection. According to data released on Thursday by the Union Health Ministry, the country experienced a total of 6,960 discharges in the last 24 hours, bringing the total recovery rate to roughly 98.40 percent, the highest since March 2020, and total recoveries data to 3,42,08,926. According to government data released today, the overall number of active COVID-19 cases in India has risen to 78,291. So now, the Nationwide Vaccination Drive has administered about 139.70 crore vaccine doses. The country''s total death toll today stands at 4,78,759. The first death from the COVID epidemic was recorded in India in March 2020. The Indian Council of Medical Research (ICMR) reports that 66,86,43,929 samples have been tested for COVID-19 as of December 22. On Wednesday, 12,05,775 of these samples were examined. Kerala Covid Review: After reporting less than 3,000 new COVID-19 cases in the previous three days, Kerala reported 3,205 new infections on Wednesday, bringing the total number of cases to 52,13,943.

New Research Study ""Auto Injectors Market 2021 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook"" has been added to Coherent Market insight The global Auto Injectors market was valued at US$ 1,904.1 Mn

Paxlovid, which comprises two types of tablet, was granted an emergency use authorization by the Food and Drug Administration (FDA) after it was shown in

The health regulator also given the green light for those whove had the Pfizer vaccine to be administered the J&J booster

The U.S. Food and Drug Administration (FDA) announced it cleared Pfizers antiviral pill, Paxlovid, to treat COVID-19. Paxlovid can be used for the treatment of mild-to-moderate COVID-19 in adults and paediatric patients (12 years of age and older weighing at least 40 kg [88 lbs]) with positive results of direct SARS-CoV-2 viral testing, and who [] The post US Approves Pfizer COVID-19 Pill For At-Home Use appeared first on TechFinancials - Reliable Tech News In South Africa .

COVID treatment pill not substitute for vaccination FDA: Paxlovid benefits outweigh the risks NASSAU, BAHAMAS The United States Food and Drug Administration (FDA) yesterday issued an emergency use authorization (EUA) for Pfizers Paxlovid oral tablets for the treatment of mild-to-moderate COVID-19 in adults and children 12 years or older, and who are at high []

9 News Australia published this video item, entitled Read more

MANILA The Philippines food and drug agency has given emergency approval for the use of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, its chief said on Thursday. The benefits outweighed the risks and it is already being used for children in countries like the United States and Canada, food and drug agency chief [] The post FDA approves use of Pfizer vaccine in children aged 5-11 appeared first on Interaksyon .

Prime Minister Hun Sen said that Pfizer donated by Australia will be used as the fourth dose to inoculate font liners at the end of this month. The post Pfizer to be used as the fourth dose for front liners appeared first on Khmer Times .

FDA authorises emergency use of Pfizers new Covid pill The United States Food and Drug Administration (FDA), on Wednesday, December 22, authorised the emergency use Pfizers new Covid-19 pill, PAXLOVID, The pharmaceutical giant has developed this first oral treatment against the coronavirus. In an official statement, the FDA, announced its decision, specifying that the pill [] The post FDA authorises emergency use of Pfizers new Covid pill appeared first on Euro Weekly News Spain .

Omicron is better able to bypass prior immunity, and health authorities are urging the public to get boosted with mRNA vaccines

Capital Nomura Securities saw positive outlook in the stock markets after the U.S. FDA granted emergency authorization to Pfizers Covid treatment pills.